Salix Pharmaceuticals and Cosmo Pharmaceuticals have called off their $2.7 billion merger, citing recent moves by the U.S. Treasury Department to make it more difficult for companies to complete ...

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the opening of the 2025 Salix Gastrointestinal Health Scholars ...

The Wall Street Journal also claimed that Allergan’s decision to bid for Salix is to hinder Valeant Pharmaceuticals International Inc.’s (VRX) proposal to acquire Allergan. Salix has several products ...

The shake-up at the top of Salix Pharmaceuticals continues. On Monday afternoon, CEO Carolyn Logan became the second C-suite executive to step down in the wake of an inventory snafu disclosed late ...

Valeant Pharmaceuticals is in the final stages of acquiring Dendreon’s cancer vaccine Provenge but is already lining up its next acquisition prospect, according to news reports. The Canadian pharma ...